Sympathetic Ophthalmia Successfully Controlled with Methotrexate

Article Sidebar

PDF
Published: Nov 17, 2014
DOI: https://doi.org/10.18192/uojm.v4i2.1151
Keywords:
Sympathetic Ophthalmia, Methotrexate, Uveitis

Main Article Content

Adrian C Tsang
1. The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2. University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada 3. University of Ottawa Eye Institute, Ottawa, Ontario, Canada
Chloe Gottlieb
1. The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada 2. University of Ottawa, Faculty of Medicine, Ottawa, Ontario, Canada 3. University of Ottawa Eye Institute, Ottawa, Ontario, Canada

Abstract

This is a case of sympathetic ophthalmia in a 31 year old man presenting five months after a penetrating globe injury to his left eye. Vision loss in the right eye was unexpected and the patient’s uveitis became refractory to prednisone treatment. The patient was successfully treated and his uveitis remains quiet with combined methotrexate and prednisone therapy. This case was well documented with fluorescein angiography and fundus photography throughout the treatment course.

 

Article Details

Issue
Vol. 4 No. 2 (2014): UOJM Volume 4, Issue 2
Section
Case Report & Elective report
  1. Authors publishing in the UOJM retain copyright of their articles, including all the drafts and the final published version in the journal.
  2. While UOJM does not retain any rights to the articles submitted, by agreeing to publish in UOJM, authors are granting the journal right of first publication and distribution rights of their articles.
  3. Authors are free to submit their works to other publications, including journals, institutional repositories or books, with an acknowledgment of its initial publication in UOJM.
  4. Copies of UOJM are distributed both in print and online, and all materials will be publicly available online. The journal holds no legal responsibility as to how these materials will be used by the public.
  5. Please ensure that all authors, co-authors and investigators have read and agree to these terms.
  6. Works are  licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

1.Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259–63.

2.Vote BJ, Hall A, Cairns J, Buttery R. Changing trends in sympathetic ophthalmia. Clin Experiment Ophthalmol 2004; 32(5):542–545.

3.Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492-513.

4.Sampangi R, Venkatesh P, Mandal S, Garg SP. Recurrent neovascularization of the disc in sympathetic ophthalmia. Indian J Ophthalmol. 2008;56(3):237.

5. Chang GC, Young LH. Sympathetic Ophthalmia. Semin Ophthalmol. 2011; 26(4-5), 316–320.